DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Market Cap | $3,324 | $1,964 | $7,782 | $34,473 |
| - Cash | $595 | $1,807 | $979 | $266 |
| + Debt | $7,283 | $1,070 | $628 | $833 |
| Enterprise Value | $10,012 | $1,227 | $7,432 | $35,040 |
| Revenue | $2,433 | $1,276 | $786 | $710 |
| % Growth | 90.7% | 62.4% | 10.7% | – |
| Gross Profit | $754 | $325 | $278 | $277 |
| % Margin | 31% | 25.5% | 35.3% | 39.1% |
| EBITDA | -$8,930 | -$2,376 | -$2,283 | -$5,195 |
| % Margin | -367% | -186.2% | -290.5% | -732% |
| Net Income | -$12,348 | -$8,716 | -$3,735 | -$7,790 |
| % Margin | -507.5% | -683.3% | -475.4% | -1,097.7% |
| EPS Diluted | -0.03 | -0.09 | -0.2 | -3.2 |
| % Growth | 66.7% | 55% | 93.8% | – |
| Operating Cash Flow | -$5,782 | -$3,606 | -$3,764 | -$1,530 |
| Capital Expenditures | -$391 | -$124 | -$57 | -$14 |
| Free Cash Flow | -$6,173 | -$3,729 | -$3,821 | -$1,544 |